Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $53.2800 (1.83%) ($52.4200 - $53.2800) on Thu. Jan. 26, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.45% (three month average) | RSI | 46 | Latest Price | $53.2800(1.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.8% a day on average for past five trading days. | Weekly Trend | HALO declines -1.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(40%) XBI(39%) IFRA(38%) IWO(34%) IWM(33%) | Factors Impacting HALO price | HALO will decline at least -1.225% in a week (0% probabilities). VXX(-15%) VIXM(-11%) UUP(-11%) GLD(-11%) IGOV(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.225% (StdDev 2.45%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $52.01(2.44%) | 10 Day Moving Average | $51.63(3.2%) | 20 Day Moving Average | $53.23(0.09%) | To recent high | -10.2% | To recent low | 16.4% | Market Cap | $7.282b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |